IFNA1 and neoplasm: A recent study showed that the intratumoral production of type I interferons (IFN-α/β) in response to ablative radiotherapy is key in this scenario, since it enhances the cross-presenting capacity of tumor-infiltrating DCs (Burnette et al. 2011).